Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 68.95M
March 31, 2026 66.13M
December 31, 2025 93.08M
September 30, 2025 76.80M
June 30, 2025 80.12M
March 31, 2025 87.28M
December 31, 2024 55.54M
September 30, 2024 84.02M
June 30, 2024 87.59M
March 31, 2024 79.40M
December 31, 2023 74.25M
September 30, 2023 40.21M
June 30, 2023 13.31M
March 31, 2023 -5.354M
December 31, 2022 -5.481M
September 30, 2022 17.13M
June 30, 2022 31.65M
March 31, 2022 33.14M
December 31, 2021 43.64M
September 30, 2021 50.43M
June 30, 2021 48.31M
March 31, 2021 49.11M
December 31, 2020 59.44M
September 30, 2020 64.62M
June 30, 2020 59.35M
Date Value
March 31, 2020 70.35M
December 31, 2019 59.05M
September 30, 2019 42.32M
June 30, 2019 47.17M
March 31, 2019 42.40M
December 31, 2018 49.55M
September 30, 2018 66.48M
June 30, 2018 70.01M
March 31, 2018 73.47M
December 31, 2017 87.74M
September 30, 2017 81.73M
June 30, 2017 98.38M
March 31, 2017 111.40M
December 31, 2016 79.35M
September 30, 2016 61.07M
June 30, 2016 37.22M
March 31, 2016 32.49M
December 31, 2015 48.54M
September 30, 2015 48.95M
June 30, 2015 68.70M
March 31, 2015 29.50M
December 31, 2014 8.654M
September 30, 2014 16.87M
June 30, 2014 -0.712M
March 31, 2014 25.49M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Zoetis, Inc. 2.887B
Merck & Co., Inc. 19.97B
ANI Pharmaceuticals, Inc. 189.47M
Corcept Therapeutics, Inc. 109.70M
Veru, Inc. -26.04M